Academia

Latest News

Based on western blot testing, patients who received gene therapy at 2 years old showed a mean dystrophin expression of 93.87% of normal. | Image Credit: Treecha - stock.adobe.com
DMD Gene Therapy Shows Efficacy, Safety in Patients Treated at 2 Years Old

May 23rd 2025

Delandistrogene moxeparvovec, a gene therapy for Duchenne muscular dystrophy (DMD), showed high dystrophin expression and a favorable safety profile in young patients.

In the phase 3 IMforte trial, patients with extensive-stage small cell lung cancer experienced clinically meaningful benefits with maintenance lurbinectedin plus atezolizumab vs atezolizumab. | Image credit: appledesign - stock.adobe.com
Lurbinectedin Plus Atezolizumab Maintenance Shows Improved Survival vs Atezolizumab in SCLC

May 22nd 2025

Data from this new study show that cutoffs as low as 2% were associated with poor outcomes in IPF, even when accounting for other known prognostic factors. | Image Credit: Crystal light - stock.adobe.com
Real-World Findings Suggest New Look at Thresholds for IPF Progression

May 22nd 2025

Future validation studies with a larger sample size are warranted to ensure the technique will be useful in a clinical setting. | Image credit: Artur Wnorowski - stock.adobe.com
Novel, Noninvasive Skin Cancer Detection Method Shows Promise

May 18th 2025

Ultrasound may be a more viable option than other methods, such as chest radiography and spirometry, to detect lung complications in rheumatoid arthritis. | Image credit: Kate - stock.adobe.com
Lung Ultrasound Can Accurately Detect ILD in Patients With RA

May 16th 2025

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo